BIO vs DHR
As of Sep 20, 2026, Bio-Rad Laboratories (BIO) scores 7.4/10 and Danaher (DHR) 4.6/10 on AlphaStocks' five-model composite, so BIO scores higher. DHR trades 52% above its model fair value.
BIO
BIO-RAD LABORATORIES, INC.
7.4
Consider Buy
$375.68
DHR
DANAHER CORP /DE/
4.6
Weak
$211.77
BIO vs DHR: Which is the Better Investment?
BIO-RAD LABORATORIES, INC. (BIO) scores 7.4/10 while DANAHER CORP /DE/ (DHR) scores 4.6/10 on AlphaStocks' composite model. BIO-RAD LABORATORIES, INC. has the higher composite rating of Consider Buy. On a P/E basis, BIO-RAD LABORATORIES, INC. trades at 13.5x, making it the more attractively priced of the two.
This comparison is algorithmically generated and is not financial advice.
| Metric | BIO | DHR |
|---|---|---|
| Scores & Fundamentals | ||
| Composite Score | 7.4/10▲ | 4.6/10 |
| Rating | Consider Buy▲ | Weak |
| Price | $375.68 | $211.77 |
| P/E Ratio | 13.5▲ | 42.0 |
| ROE | 9.7%▲ | 7.0% |
| Market Cap | $10B | $151B |
| Fair Value | — | $139.67 |
| Dividend Yield | — | 0.6% |
| Sector Rank | #7 of 168▲ | #125 of 168 |
| Model Verdicts | ||
| Piotroski | Attractive | Attractive |
| Buffett | Neutral | Neutral |
| Graham | Attractive▲ | Neutral |
| Lynch | Attractive▲ | Neutral |
| Greenblatt | Strong▲ | Neutral |
Related comparisons
BIO vs DHR: Which Stock Scores Higher?
BIO-RAD LABORATORIES, INC. (BIO) and DANAHER CORP /DE/ (DHR) are both in the Health Care sector. BIO currently leads with a composite score of 7.4/10 (Consider Buy) compared to DHR's 4.6/10 (Weak).
The AlphaStocks composite score evaluates each stock across four dimensions: Quality (business strength measured by Piotroski F-Score and Buffett quality criteria), Value (discount to intrinsic worth using Graham, Lynch, and Greenblatt models), Momentum (6-month price trend), and Timing (a confirmation signal that requires both value and momentum to align). A higher composite score indicates stronger overall fundamentals combined with favorable market conditions.
This comparison uses the same scoring framework for both companies, ensuring an apples-to-apples evaluation. Scores are recalculated daily after market close using data from SEC filings and market prices. Read the full methodology to understand how each model contributes to the composite score.
Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer